TY - JOUR
KW - Adult
KW - Analgesics, Opioid/therapeutic use
KW - Antiviral Agents/therapeutic use
KW - Coinfection
KW - Databases, Factual
KW - Female
KW - HIV Infections/complications/drug therapy/psychology
KW - Hepatitis C/complications/drug therapy/psychology
KW - Humans
KW - Male
KW - Medication Adherence
KW - Retrospective Studies
KW - Substance Abuse, Intravenous/complications/drug therapy/psychology
KW - Time Factors
KW - HIV
KW - Hepatitis C virus
KW - opioid agonist treatment
KW - People who inject drugs
AU - Dimitra Panagiotoglou
AU - Emanuel Krebs
AU - Jeong Eun Min
AU - Michelle Olding
AU - Keith Ahamad
AU - Lianping Ti
AU - Julio S. G. Montaner
AU - Bohdan Nosyk
A1 - 
AD - BC Centre for Excellence in HIV/AIDS, Vancouver, Canada. Electronic address: dpanagiotoglou@cfenet.ubc.ca.; BC Centre for Excellence in HIV/AIDS, Vancouver, Canada.; BC Centre for Excellence in HIV/AIDS, Vancouver, Canada.; BC Centre for Excellence in HIV/AIDS, Vancouver, Canada.; BC Centre for Excellence in HIV/AIDS, Vancouver, Canada; Department of Family Medicine, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; BC Centre for Excellence in HIV/AIDS, Vancouver, Canada; Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; BC Centre for Excellence in HIV/AIDS, Vancouver, Canada; Division of AIDS, Faculty of Medicine, University of British Columbia, Vancouver, Canada.; BC Centre for Excellence in HIV/AIDS, Vancouver, Canada; Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada.
BT - The International journal on drug policy
C5 - Healthcare Disparities; Opioids & Substance Use
CY - Netherlands
DO - 10.1016/j.drugpo.2017.05.021
JF - The International journal on drug policy
LA - eng
M1 - Journal Article
PB - Elsevier B.V
PP - Netherlands
PY - 2017
SN - 1873-4758; 0955-3959
SP - 169
EP - 176
EP - 
T1 - Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?
T2 - The International journal on drug policy
TI - Initiating HCV treatment with direct acting agents in opioid agonist treatment: When to start for people co-infected with HIV?
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 28578865
U3 - 10.1016/j.drugpo.2017.05.021
VL - 47
VO - 1873-4758; 0955-3959
Y1 - 2017
Y2 - Sep
ER -